Treatment of sickle cell disease and inflammatory conditions
US10350228B2 · kind B2 · utility
1Cited by
30References
18Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 22, 2013 |
| Grant date | Jul 16, 2019 |
| Priority date | — |
| Expiry date | Aug 26, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P7/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides methods and compositions for the treatment of sickle cell disease and other inflammatory conditions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.